Drug Trial Radar · NCT01698164
Multi-centre Clinical Trial on Hormone Replacement Treatment in China
Last checked: Nov 19, 2026Latest source record: Oct 2, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
1,200
Planned (sponsor's estimate)
Start
Dec 2008
Primary completion
Oct 2012
Sponsor
- Lead sponsor
- Peking Union Medical College HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 2, 2012
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 40 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is to evaluate the benefit/risk of hormone replacement treatment among early menopausal women in China. This is a multi-centre, random, prospective study.
Conditions
- Menopausal Syndrome
- Cardiovascular Disease
- Osteoporosis
- Breast Cancer
Interventions
estradiol plus MPADrug
Participants are given estradiol and synthetic progestin.
Ximingting TabletDrug
Participants are given phytoestrogen.
estradiol plus progesteroneDrug
Participants are given estradiol and natural progesterone.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in risk factors of cardiovascular disease at 12 months and 24 monthsTime frame: before the treatment, time point of taking the medicine for 1 year, time point of taking the medicine for 2 years
- Change from Baseline in risk factors of breast cancer at 12 months and 24 monthsTime frame: before the treatment, time point of taking the medicine for 1 year, time point of taking the medicien for 2 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
PUMCH
Beijing, Beijing Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.